{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:56:39Z","timestamp":1788317799787,"version":"build-2803163510"},"reference-count":33,"publisher":"American Chemical Society (ACS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2009,2,26]]},"DOI":"10.1021\/jm801332q","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T19:25:35Z","timestamp":1233689135000},"page":"1180-1189","source":"Crossref","is-referenced-by-count":29,"title":["Discovery of <i>N<\/i>-(3-Fluorophenyl)-1-[(4-([(3<i>S<\/i>)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the First Small Molecule Motilin Receptor Agonist Clinical Candidate"],"prefix":"10.1021","volume":"52","author":[{"given":"Susan M.","family":"Westaway","sequence":"first","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Brown","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C. M.","family":"Fell","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher N.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"MacPherson","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Myatt","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Stanway","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon T.","family":"Seal","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Stemp","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Thompson","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Lawless","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"McKay","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison I.","family":"Muir","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Barford","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chermaine","family":"Cluff","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhia R.","family":"Mahmood","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L.","family":"Matthews","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyam","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Smith","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Stevens","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria J.","family":"Bolton","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma M.","family":"Jarvie","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J.","family":"Sanger","sequence":"additional","affiliation":[{"name":"Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K., Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K., and Molecular Discovery Research, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2009,2,3]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2982.2006.00760.x","volume":"18","author":"Abell T. L.","year":"2006","journal-title":"Neurogastroenterol. Motil."},{"key":"ref2\/cit2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1440-1746.2006.04493.x","volume":"22","author":"Hiyama T.","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref3\/cit3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MCC.0b013e3280523a88","volume":"13","author":"Chapman M. J.","year":"2007","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref4\/cit4","doi-asserted-by":"crossref","first-page":"G470","DOI":"10.1152\/ajpcell.1989.257.3.C470","volume":"257","author":"Peeters T.","year":"1989","journal-title":"Am. J. Physiol."},{"key":"ref5\/cit5","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1126\/science.284.5423.2184","volume":"284","author":"Feighner S. D.","year":"1999","journal-title":"Science"},{"key":"ref6\/cit6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2004.07.022","volume":"124","author":"Xu L.","year":"2005","journal-title":"Regul. Pept."},{"key":"ref7\/cit7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00535-005-1739-0","volume":"41","author":"Takeshita E.","year":"2006","journal-title":"J. Gastroenterol."},{"key":"ref8\/cit8a","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0196-9781(96)00333-6","volume":"18","author":"Itoh Z.","year":"1997","journal-title":"Peptides"},{"key":"ref8\/cit8b","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrd2444","volume":"7","author":"Sanger G. J.","year":"2008","journal-title":"Nat. Rev. Drug Discovery"},{"key":"ref9\/cit9a","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0016-5085(79)91315-5","volume":"76","author":"Christofides N. D.","year":"1979","journal-title":"Gastroenterology"},{"key":"ref9\/cit9b","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0016-5085(92)91788-6","volume":"102","author":"Peeters T. L.","year":"1992","journal-title":"Gastroenterology"},{"key":"ref10\/cit10","first-page":"198","volume":"88","author":"Mantides A.","year":"1993","journal-title":"Am. J. Gastroenterol."},{"key":"ref11\/cit11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2982.2005.00749.x","volume":"18","author":"Peeters T. L.","year":"2006","journal-title":"Neurogastroenterol. Motil."},{"key":"ref12\/cit12a","volume-title":"Functional Disorders of the Gastrointestinal Tract","author":"Sann H.","year":"2005"},{"key":"ref12\/cit12b","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2036.2004.02066.x","volume":"20","author":"Russo A.","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref13\/cit13a","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1046\/j.1365-2036.1997.00260.x","volume":"11","author":"Verhagen M. A. M. T.","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref13\/cit13b","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1365-2036.2000.00868.x","volume":"14","author":"Talley N. J.","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref13\/cit13c","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/gut.49.3.395","volume":"49","author":"Talley N. J.","year":"2001","journal-title":"Gut"},{"key":"ref14\/cit14a","first-page":"317","volume":"49","author":"Tack J","year":"2001","journal-title":"Gut"},{"key":"ref14\/cit14b","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/MED.0b013e3282f370af","volume":"15","author":"Poitras P.","year":"2008","journal-title":"Curr. Opin. Endocrinol., Diabetes Obes."},{"key":"ref14\/cit14c","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2982.2008.01084.x","volume":"20","author":"Sanger G. J.","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"ref14\/cit14d","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drudis.2007.10.024","volume":"13","author":"Sanger G. J.","year":"2008","journal-title":"Drug Discovery Today"},{"key":"ref15\/cit15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.2007.03346.x","volume":"26","author":"Mccallum R. W.","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref16\/cit16","unstructured":"Jasserand, D.; Antel, J.; Preuschoff, U.; Brueckner, R.; Sann, H.; Wurl, M.; Eickelmann, P.PCT Int. Appl. WO 2002092592, CAN 137:384755, 2002."},{"key":"ref17\/cit17","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/jm0304865","volume":"47","author":"Li J. J.","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref18\/cit18","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1016\/j.bmcl.2008.10.071","volume":"18","author":"Heightman T. D.","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref19\/cit19","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1016\/j.bmcl.2008.10.072","volume":"18","author":"Westaway S. M.","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref20\/cit20","unstructured":"Johnson, C. N.; Macpherson, D. T.; Stanway, S. J.; Stemp, G.; Thompson, M.; Westaway, S. M.Preparation of Benzylpiperazine Derivatives as Agonists of GPR38 Receptors. PCT Int. Appl. WO 2007012479, 2007."},{"key":"ref21\/cit21","unstructured":"The potency data quoted for compound6(and all other compounds) in this paper are those obtained using the recombinant human motilin receptor expressed in a CHO cell line (seeExperimental Sectionfor details), whereas that given previously(19)was obtained using a HEK293 cell line. There is a shift in potency between the two assay formats, but the rank order of potency remains consistent; see ref19for a comparison of potency data for standard compounds. In addition, the CYP inhibition data given in this paper were obtained using enzyme sourced from Cypex whereas those given previously were obtained using enzyme sourced from Gentest; hence, there is some variation in the data quoted in this publication and in ref19."},{"key":"ref22\/cit22","unstructured":"pEC50data quoted are the mean of at least three values with SEM \u2264 0.3 in all cases except for compounds7and8, wheren= 2."},{"key":"ref23\/cit23","unstructured":"SeeExperimental Sectionfor the method used to assess time dependent inhibition (TDI) of CYP3A4."},{"key":"ref24\/cit24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bjp.0707118","volume":"150","author":"Jarvie E. M.","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref25\/cit25","author":"Sanger G. J.","journal-title":"Neurogastroenterol. Motil."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/jm801332q","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T08:11:53Z","timestamp":1680855113000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/jm801332q"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,3]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,2,26]]}},"alternative-id":["10.1021\/jm801332q"],"URL":"https:\/\/doi.org\/10.1021\/jm801332q","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,3]]}}}